Showing results (751-760 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|October 29, 2015
Hydrogen-rich saline may be an effective and specific novel treatment for osteoradionecrosis of the jawYuanli Chen, Chunlin Zong, Yuxuan Guo, et al.Therapeutics and Clinical Risk Management|June 18, 2016
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseaseFeliciano Chanana PaquissiTherapeutics and Clinical Risk Management|June 10, 2016
Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infectionsStephanie E Giancola, Monica V Mahoney, Tiffany E Bias, et al.Therapeutics and Clinical Risk Management|May 23, 2019
Effect of using the Suction Above Cuff Endotracheal Tube (SACETT) on postoperative respiratory complications in rhinoplasty: a randomized prospective controlled trialNureddin Yuzkat, Canser Yilmaz DemirTherapeutics and Clinical Risk Management|May 24, 2019
Total knee arthroplasty associated with tibial tubercle and simultaneous femoral and tibial osteotomies for severe extra-articular deformity: a case reportPavel Sponer, Tomas KuceraTherapeutics and Clinical Risk Management|May 24, 2019
Rivaroxaban in atrial fibrillation cardioversion: an updateCarlo Lavalle, Martina Straito, Annalisa Caroli, et al.Therapeutics and Clinical Risk Management|September 27, 2018
Sanders type 3-4 calcaneal fractures fixed with locking plate: does tri-cortical iliac bone autograft provide extra benefit for stabilization?Tugrul Bulut, Merve Gursoy, Tahir Ozturk, et al.Therapeutics and Clinical Risk Management|September 27, 2018
Combined reperfusion therapy to treat cryptogenic acute ischemic stroke during the first trimester of pregnancy: case report and literature reviewFrançois Zhu, Benjamin Gory, Gioia Mione, et al.Therapeutics and Clinical Risk Management|July 28, 2018
Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumorsDazhi Liu, Michael Offin, Stephen Harnicar, et al.Therapeutics and Clinical Risk Management|June 9, 2018
Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolizationQing Li, Tao Wu, Xiao-An Ma, et al.Pageof 256